A detailed history of Laurion Capital Management LP transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Laurion Capital Management LP holds 3,189,547 shares of AUTL stock, worth $8.23 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
3,189,547
Previous 3,646,230 12.52%
Holding current value
$8.23 Million
Previous $12.7 Million 8.75%
% of portfolio
0.16%
Previous 0.15%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.38 - $4.69 $1.54 Million - $2.14 Million
-456,683 Reduced 12.52%
3,189,547 $11.6 Million
Q2 2024

Aug 14, 2024

BUY
$3.33 - $5.68 $5.18 Million - $8.84 Million
1,555,759 Added 74.42%
3,646,230 $12.7 Million
Q1 2024

May 15, 2024

BUY
$5.39 - $7.29 $6.49 Million - $8.78 Million
1,205,000 Added 136.09%
2,090,471 $13.3 Million
Q4 2023

Feb 14, 2024

SELL
$2.13 - $6.63 $1.31 Million - $4.07 Million
-614,529 Reduced 40.97%
885,471 $5.7 Million
Q4 2022

Feb 14, 2023

BUY
$1.74 - $3.27 $2.61 Million - $4.91 Million
1,500,000 New
1,500,000 $2.85 Million
Q2 2021

Aug 13, 2021

SELL
$4.78 - $7.96 $730,608 - $1.22 Million
-152,847 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$5.49 - $9.36 $839,130 - $1.43 Million
152,847 New
152,847 $876,000
Q3 2020

Nov 13, 2020

SELL
$11.64 - $16.3 $785,921 - $1.1 Million
-67,519 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$5.38 - $16.14 $275,536 - $826,610
-51,215 Reduced 43.13%
67,519 $1.08 Million
Q1 2020

May 14, 2020

BUY
$4.2 - $13.0 $498,682 - $1.54 Million
118,734 New
118,734 $711,000
Q3 2019

Nov 13, 2019

SELL
$9.79 - $16.72 $443,624 - $757,650
-45,314 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$15.1 - $31.25 $684,241 - $1.42 Million
45,314 New
45,314 $730,000
Q4 2018

Feb 14, 2019

SELL
$24.21 - $48.01 $585,639 - $1.16 Million
-24,190 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$20.86 - $33.33 $1.06 Million - $1.69 Million
-50,810 Reduced 67.75%
24,190 $730,000
Q2 2018

Aug 13, 2018

BUY
$25.0 - $27.75 $1.88 Million - $2.08 Million
75,000 New
75,000 $2.01 Million

Others Institutions Holding AUTL

About Autolus Therapeutics plc


  • Ticker AUTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,909,800
  • Market Cap $235M
  • Description
  • Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...
More about AUTL
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.